Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 33,365Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Janssen Inc.

02 1Schering-Plough Canada Inc.

03 1UPS SCS, Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

Doxorubicin Hydrochloride

Brand Name : CAELYX

Patent Number : 1335565

Filing Date : 1989-09-19

Strength per Unit : 2 mg/ml

Dosage Form : Sterile Suspension for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2012-05-16

Date Granted : 1995-05-16

blank

02

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

Doxorubicin Hydrochloride

Brand Name : CAELYX

Patent Number : 2067178

Filing Date : 1990-10-19

Strength per Unit : 2 mg/ml

Dosage Form : Sterile Suspension for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2010-10-19

Date Granted : 1997-03-25

blank

03

arrow
Coatings Trends
Not Confirmed

UPS SCS, Inc.

Country
arrow
Coatings Trends
Not Confirmed

Doxorubicin Hydrochloride

Brand Name : MYOCET

Patent Number : 1338702

Filing Date : 1988-02-29

Strength per Unit : 2 mg/ml

Dosage Form : Lyophilized Powder

Human Or VET : Human

Route of Administration : Intravenous Infusion

Patent Expiration Date : 2013-11-12

Date Granted : 1998-11-12

blank